Fusion Genomics Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Fusion Genomics's estimated annual revenue is currently $2.3M per year.(i)
  • Fusion Genomics's estimated revenue per employee is $155,000

Employee Data

  • Fusion Genomics has 15 Employees.(i)
  • Fusion Genomics grew their employee count by -29% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$3.1M4018%$40MN/A
#2
$0.2M20%N/AN/A
#3
$1.2M1623%N/AN/A
#4
$2.5M16-20%N/AN/A
#5
$12.2M797%N/AN/A
#6
$1.8M2315%$89.5MN/A
#7
$2.5M160%N/AN/A
#8
$40.3M26021%N/AN/A
#9
$0.9M60%N/AN/A
#10
$0.9M6200%N/AN/A
Add Company

Fusion Genomics is a Vancouver-based biotechnology company that is pushing the frontiers of molecular diagnostics with proprietary technologies, combined with Next Generation Sequencing, to create genomic testing for pathogens. Fusion Genomics is seeking to tackle the global problem of idiopathic infections, which cost the global economy billions of dollars in hospitalizations and lost productivity and exact a heavy human toll in hundreds of lost lives. Fusion Genomics' disruptive DNA and RNA capture technology, part of a "benchtop to desktop solution" called the ONETestᵀᴹ platform enables the comprehensive identification of pathogens from virtually any source, including blood, sputum, stool, swabs, and cell free extracts, in eight to twelve hours. The platform uses Fusion Genomics proprietary UNIPrepᵀᴹ, QUANTUMProbesᵀᴹ, and FusionCloudᵀᴹ technologies and offers 10,000x the sensitivity, accuracy across 20% genetics distance, and at one-tenth the cost. The ONETestᵀᴹ platform has been validated by international laboratories working on behalf of the European Union and various Canadian public health agencies. For more information about Fusion Genomics diagnostic technologies or to explore investor opportunities, please contact: info@fusiongenomics.com

keywords:N/A

N/A

Total Funding

15

Number of Employees

$2.3M

Revenue (est)

-29%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Fusion Genomics News

2022-04-06 - SARS-CoV-2 spike protein–induced cell fusion activates the ...

... the fusion of the viral membrane with the plasma membrane, culminating in the delivery of viral genomic RNA into the cytoplasm for replication (7–9).

2022-03-30 - Dual-gRNA approach with limited off-target effect corrects ...

With the advances of genome editing approaches, especially the ... In addition, the dual gRNAs remove repeat DNA with a high fusion...

2022-03-22 - Fusion Genomics ONETest Selected for Pilot Pandemic ...

Fusion Genomics is a molecular diagnostics company focused on transforming infectious disease through advanced genomic technologies. Fusion is...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.8M157%N/A
#2
$2.4M16-43%N/A
#3
$1.5M17N/AN/A
#4
$2.8M17N/AN/A
#5
$0.7M1838%N/A